• 1
    Cummings SR, Karpf DB, Harris F, Genant HK, Ensrud K, LaCroix AZ, Black DM. Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs. Am J Med. 2002; 112(4): 2819.
  • 2
    Delmas PD, Seeman E. Changes in bone mineral density explain little of the reduction in vertebral or nonvertebral fracture risk with anti-resorptive therapy. Bone. 2004; 34(4): 599604.
  • 3
    Parfitt AM. Use of bisphosphonates in the prevention of bone loss and fractures. Am J Med. 1991; 91(5B): 42S6S.
  • 4
    Dempster DW. The contribution of trabecular architecture to cancellous bone quality. J Bone Miner Res. 2000; 15(1): 203.
  • 5
    Parfitt AM. High bone turnover is intrinsically harmful: two paths to a similar conclusion. The Parfitt view. J Bone Miner Res. 2002; 17(8): 15589.
  • 6
    Einhorn TA. Bone strength: the bottom line. Calcif Tissue Int. 1992; 51(5): 3339.
  • 7
    Slyfield CR, Tkachenko EV, Fischer SE, Ehlert KM, Yi IH, Jekir MG, O'Brien RG, Keaveny TM, Hernandez CJ. Mechanical failure begins preferentially near resorption cavities in human vertebral cancellous bone under compression. Bone. Epub 2012 Mar 8. DOI: 10.1016/j.bone.2012.02.636.
  • 8
    Hernandez CJ, Gupta A, Keaveny TM. A biomechanical analysis of the effects of resorption cavities on cancellous bone strength. J Bone Miner Res. 2006; 21(8): 124855.
  • 9
    Gluer CC, Scholz-Ahrens KE, Helfenstein A, Delling G, Timm W, Acil Y, Barkmann R, Hassenpflug J, Stampa B, Bauss F, Schrezenmeir J. Ibandronate treatment reverses glucocorticoid-induced loss of bone mineral density and strength in minipigs. Bone. 2007; 40(3): 64555.
  • 10
    Ominsky MS, Stouch B, Schroeder J, Pyrah I, Stolina M, Smith SY, Kostenuik PJ. Denosumab, a fully human RANKL antibody, reduced bone turnover markers and increased trabecular and cortical bone mass, density, and strength in ovariectomized cynomolgus monkeys. Bone. 2011; 49(2): 16273.
  • 11
    Balena R, Toolan BC, Shea M, Markatos A, Myers ER, Lee SC, Opas EE, Seedor JG, Klein H, Frankenfield D, et al. The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates. J Clin Invest. 1993; 92(6): 257786.
  • 12
    Lafage MH, Balena R, Battle MA, Shea M, Seedor JG, Klein H, Hayes WC, Rodan GA. Comparison of alendronate and sodium fluoride effects on cancellous and cortical bone in minipigs. A one-year study. J Clin Invest. 1995; 95(5): 212733.
  • 13
    Allen MR, Iwata K, Phipps R, Burr DB. Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate. Bone. 2006; 39(4): 8729.
  • 14
    Hildebrand T, Laib A, Müller R, Dequeker J, Rüegsegger P. Direct three-dimensional morphometric analysis of human cancellous bone: microstructural data from spine, femur, iliac crest, and calcaneus. J Bone Miner Res. 1999; 14(7): 116774.
  • 15
    Mosekilde L. Consequences of the remodelling process for vertebral trabecular bone structure: a scanning electron microscopy study (uncoupling of unloaded structures). Bone Miner. 1990; 10(1): 1335.
  • 16
    Parfitt AM. Osteonal and hemi-osteonal remodeling: the spatial and temporal framework for signal traffic in adult human bone. J Cell Biochem. 1994; 55(3): 27386.
  • 17
    Eriksen EF, Hodgson SF, Eastell R, Cedel SL, O'Fallon WM, Riggs BL. Cancellous bone remodeling in type I (postmenopausal) osteoporosis: quantitative assessment of rates of formation, resorption, and bone loss at tissue and cellular levels. J Bone Miner Res. 1990; 5(4): 3119.
  • 18
    Heaney RP. The bone-remodeling transient: implications for the interpretation of clinical studies of bone mass change. J Bone Miner Res. 1994; 9(10): 151523.
  • 19
    Bevill G, Eswaran SK, Gupta A, Papadopoulos P, Keaveny TM. Influence of bone volume fraction and architecture on computed large-deformation failure mechanisms in human trabecular bone. Bone. 2006; 39(6): 121825.
  • 20
    Papadopoulos P, Lu J. On the formulation and numerical solution of problems in anisotropic finite plasticity. Comput Methods Appl Mech Eng. 2001; 190(37–38): 4889910.
  • 21
    Bevill G, Eswaran SK, Farahmand F, Keaveny TM. The influence of boundary conditions and loading mode on high-resolution finite element-computed trabecular tissue properties. Bone. 2009; 44(4): 5738.
  • 22
    Eswaran SK, Allen MR, Burr DB, Keaveny TM. A computational assessment of the independent contribution of changes in canine trabecular bone volume fraction and microarchitecture to increased bone strength with suppression of bone turnover. J Biomech. 2007; 40(15): 342431.
  • 23
    Adams MF, Bayraktar HH, Keaveny TM, Papadopoulos P. Ultrascalable implicit finite element analyses in solid mechanics with over a half a billion degrees of freedom. Proceedings of the ACM/IEEE SC2004 Conference; 2004 Nov 6-12. DOI:10.1109/SC.2004.62.
  • 24
    Hernandez CJ, Keaveny TM. A biomechanical perspective on bone quality. Bone. 2006; 39(6): 117381.
  • 25
    Allen MR, Burr DB. Changes in vertebral strength-density and energy absorption-density relationships following bisphosphonate treatment in beagle dogs. Osteoporos Int. 2008; 19(1): 959.
  • 26
    Tkachenko EV, Slyfield CR, Tomlinson RE, Daggett JR, Wilson DL, Hernandez CJ. Voxel size and measures of individual resorption cavities in three-dimensional images of cancellous bone. Bone. 2009; 45: 48792.
  • 27
    Allen MR, Erickson AM, Wang X, Burr DB, Martin RB, Hazelwood SJ. Morphological assessment of basic multicellular unit resorption parameters in dogs shows additional mechanisms of bisphosphonate effects on bone. Calcif Tissue Int. 2010; 86(1): 6771.
  • 28
    Boyce RW, Paddock CL, Gleason JR, Sletsema WK, Eriksen EF. The effects of risedronate on canine cancellous bone remodeling: three-dimensional kinetic reconstruction of the remodeling site. J Bone Miner Res. 1995; 10(2): 21121.
  • 29
    Jaworski ZF, Lok E. The rate of osteoclastic bone erosion in Haversian remodeling sites of adult dog's rib. Calcif Tissue Res. 1972; 10(2): 10312.
  • 30
    van der Linden JC, Verhaar JA, Weinans H. A three-dimensional simulation of age-related remodeling in trabecular bone. J Bone Miner Res. 2001; 16(4): 68896.
  • 31
    Hernandez CJ, Gupta A, Keaveney TM. Remodeling cavities and stress risers: A biomechanical study on cancellous bone strength. J Bone Miner Res. 2005; 20(9): S162.
  • 32
    Hou FJ, Lang SM, Hoshaw SJ, Reimann DA, Fyhrie DP. Human vertebral body apparent and hard tissue stiffness. J Biomech. 1998; 31(11): 100915.
  • 33
    Keaveny TM. Mechanistic approaches to analysis of trabecular bone. Forma. 1997; 12: 26775.
  • 34
    Cowin S. Bone mechanics handbook. 2nd ed. Boca Raton, FL: CRC Press; 2001. p. 968.